Abstract:Background Cryoablation is a minimally invasive option for patients with medically inoperable non-small cell lung cancer (NSCLC) and can trigger abscopal immune-regulatory effects. However, it remains unclear how cryoablation affects the host-level immune response in NSCLC. In this study, we investigated the local and systemic immunological effects of cryoablation and the potential of combining cryoablation with programmed cell death protein 1 (PD-1) blockade to boost immunotherapy efficacy in NSCLC. Methods We first investigated systemic immunological effects induced by cryoablation in patients with early-stage NSCLC. Subsequently, we explored cryoablation-induced antitumor immunity and the underlying biological mechanisms using KP ( Kras G12D/+ , Tp53 −/− ) mutant lung cancer cell allograft mouse models. Moreover, the synergistic efficacy of cryoablation and PD-1 blockade was explored in both mouse models and patients with unresectable NSCLC. Results We found that cryoablation significantly increased circulating CD8 + T cell subpopulations and proinflammatory cytokines in patients with early-stage NSCLC. In lung cancer cell allograft mouse models, we demonstrated that cryoablation resulted in abscopal growth inhibition of contralateral, non-ablated tumors. Integrated analysis of bulk, single-cell RNA and T cell receptor (TCR) sequencing data revealed that cryoablation reprogrammed the intratumoral immune microenvironment and increased CD8 + T cell infiltration with higher effector signature, interferon (IFN) response, and cytolytic activity. Mechanistically, cryoablation promoted antitumor effect through the STING-dependent type I IFN signaling pathway, and type I IFN signaling blockade attenuated this antitumor effect. We also found that the combination of PD-1 blockade with cryoablation further inhibited tumor growth compared with either treatment alone in an allograft mouse model. Moreover, the combination therapy induced notable tumor suppression and CD8 + T cell infiltration in patients with unresectable NSCLC. Conclusions Our results provide mechanistic insights into how cryoablation triggers the antitumor immune effect in lung cancer, thereby potentiating programmed cell death ligand 1 (PD-L1)/PD-1 blockade efficacy in the clinical treatment of NSCLC.

Cryoablation with KCl Solution Enhances Necrosis and Apoptosis of HepG2 Liver Cancer Cells

Cryoablation combined with dual immune checkpoint blockade enhances antitumor efficacy in hepatocellular carcinoma model mice

Thermal Ablation in the Liver: Heat versus Cold—What Is the Role of Cryoablation?

Enhanced Killing of HepG2 During Cryosurgery with Fe3O4-nanoparticle Improved Intracellular Ice Formation and Cell Dehydration

Potent Induction of Antitumor Immunity by Combining Cryo-Thermal Ablation with Immune Checkpoint Inhibitors in Hepatocellular Carcinoma

Investigation of Lung Cancer Cell Response to Cryoablation and Adjunctive Gemcitabine-Based Cryo-Chemotherapy Using the A549 Cell Line

Cryoablation triggers type I interferon-dependent antitumor immunity and potentiates immunotherapy efficacy in lung cancer

Cryohepatectomy for Liver Cancer: Preliminary Evaluation of Reducing Postoperative Recurrence

Modern cancer therapy: cryoablation meets immune checkpoint blockade

Cryotherapy for Primary Liver Cancer

The Role of Cryosurgery in the Treatment of Hepatic Cancer: a Report of 113 Cases.

An electron-microscopic study of changes in hepatocellular carcinoma after cryoablation

Immune Effects of Cryoablation in Woodchuck Hepatocellular Carcinoma

Sorafenib Combined with Cryoablation to Treat Unresectable Hepatocellular Carcinoma

Percutaneous cryoablation after chemoembolization or radiotherapy for liver malignancy (45 cases report)

Effect of Hepatic Blood Flow Alteration on the Therapeutic Effect of Cryoablation in VX2 Hepatic Tumor Rabbit:An Experimental Study

The Deactivation of Lung Cancer Cells by Targeted Ar-He Cryoablation

[The efficacy and safety of computed tomography-guided percutaneous cryoablation for malignant liver tumors at high-risk sites]

Ablation Effects of Noninvasive Radiofrequency Field-Induced Hyperthermia on Liver Cancer Cells

Fe3O4 nanoparticles and cryoablation enhance ice crystal formation to improve the efficiency of killing breast cancer cells.

Anti-PD-L1 Antibody Enhances Curative Effect of Cryoablation Via Antibody-Dependent Cell-Mediated Cytotoxicity Mediating PD-L1highCD11b+ Cells Elimination in Hepatocellular Carcinoma.